Summation
- Daniel Yeager is the new Senior Vice President of Market Development of The Wound Pros, who specializes in the treatment and management of chronic non-healing wounds in long-term care facilities.
- The physician-owned and managed company is also an accredited supplier of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and a participating Medicare Part B provider.
- As Senior Vice President of Market Development, he will prioritize the continuous growth and refinement of The Wound Pros market expansion and business strategies.
December 23, 2020
Daniel Yeager is the new Senior Vice President of Market Development of The Wound Pros, who specializes in the treatment and management of chronic non-healing wounds in long-term care facilities. The physician-owned and managed company is also an accredited supplier of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and a participating Medicare Part B provider.
Daniel Yeager is a business professional with a vast amount of experience in sales, marketing, training, business development, and strategic planning. He graduated with honors from Capella University, Minnesota, earning a Bachelor’s Degree in Business Administration. With almost ten years of work experience, Daniel has developed a unique skill set that portrays excellence in his work ethic, dedication, and commitment to professional and personal growth. As Senior Vice President of Market Development, he will prioritize the continuous growth and refinement of The Wound Pros market expansion and business strategies.
Despite the COVID-19 pandemic, 2020 has been a remarkable year for The Wound Pros. The company has rapidly grown and expanded its operations into 16 states of the U.S. This year, it introduced RITA, an AI-enabled wound measurement app for assessing patients’ wounds at the bedside or remotely and generating relevant documentation to support wound care teams. In response to the pandemic, it developed a camera-based health and wellness monitoring app for tracking variations in users’ vital signs, including heart rate, respiratory rate, heart rate variability (HRV), oxygen saturation, mental stress, and blood pressure. Routine monitoring of vital signs, particularly oxygen saturation can effectively predict COVID-19 infection to curb the spread.
